Institutional Repository of Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing 100190, Peoples R China
A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy | |
Song, Jiangdian1,2,3; Shi, Jingyun4; Dong, Di1,5; Fang, Mengjie1,5; Zhong, Wenzhao6; Wang, Kun1,5; Wu, Ning7,8; Huang, Yanqi9; Liu, Zhenyu1,5; Cheng, Yue10; Gan, Yuncui10; Zhou, Yongzhao10; Zhou, Ping10; Chen, Bojiang10; Liang, Changhong9; Liu, Zaiyi9; Li, Weimin10; Tian, Jie1,5,11 | |
发表期刊 | CLINICAL CANCER RESEARCH |
2018-08-01 | |
卷号 | 24期号:15页码:3583-3592 |
文章类型 | Article |
摘要 | Purpose: We established a CT-derived approach to achieve accurate progression-free survival (PFS) prediction to EGFR tyrosine kinase inhibitors (TKI) therapy in multicenter, stage IV EGFR-mutated non-small cell lung cancer (NSCLC) patients. |
关键词 | EGFR-TKI therapy |
WOS标题词 | Science & Technology ; Life Sciences & Biomedicine |
DOI | 10.1158/1078-0432.CCR-17-2507 |
关键词[WOS] | CELL LUNG-CANCER ; TYROSINE KINASE INHIBITORS ; OPEN-LABEL ; ACQUIRED-RESISTANCE ; PHASE-III ; 1ST-LINE ERLOTINIB ; MUTATIONS ; CHEMOTHERAPY ; TRIAL ; MULTICENTER |
收录类别 | SCI |
语种 | 英语 |
项目资助者 | Natural Science Foundation of China(81771924 ; National Key R&D Program of China(2017YFA0205200 ; Science and Technology Service Network Initiative of the Chinese Academy of Sciences(KFJ-SW-STS-160) ; Instrument Developing Project of the Chinese Academy of Sciences(YZ201502) ; Beijing Municipal Science and Technology Commission(Z171100000117023 ; Youth Innovation Promotion Association CAS ; 81501616 ; 2017YFC1308700 ; Z161100002616022) ; 61671449 ; 2017YFC1308701 ; 61231004 ; 2017YFC1309100) ; 81671854 ; 81501549) |
WOS研究方向 | Oncology |
WOS类目 | Oncology |
WOS记录号 | WOS:000440600200014 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.ia.ac.cn/handle/173211/21847 |
专题 | 中国科学院分子影像重点实验室 |
作者单位 | 1.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing, Peoples R China 2.China Med Univ, Sch Med Informat, Shenyang, Liaoning, Peoples R China 3.Northeastern Univ, Sino Dutch Biomed & Informat Engn Sch, Shenyang, Liaoning, Peoples R China 4.Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Radiol, Shanghai, Peoples R China 5.Univ Chinese Acad Sci, Beijing, Peoples R China 6.Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China 7.Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, PET CT Ctr, Beijing, Peoples R China 8.Peking Union Med Coll, Beijing, Peoples R China 9.Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China 10.West China Hosp, Dept Resp & Crit Care Med, Chengdu, Sichuan, Peoples R China 11.Beijing Key Lab Mol Imaging, Beijing, Peoples R China |
第一作者单位 | 中国科学院自动化研究所 |
推荐引用方式 GB/T 7714 | Song, Jiangdian,Shi, Jingyun,Dong, Di,et al. A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy[J]. CLINICAL CANCER RESEARCH,2018,24(15):3583-3592. |
APA | Song, Jiangdian.,Shi, Jingyun.,Dong, Di.,Fang, Mengjie.,Zhong, Wenzhao.,...&Tian, Jie.(2018).A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy.CLINICAL CANCER RESEARCH,24(15),3583-3592. |
MLA | Song, Jiangdian,et al."A New Approach to Predict Progression-free Survival in Stage IV EGFR-mutant NSCLC Patients with EGFR-TKI Therapy".CLINICAL CANCER RESEARCH 24.15(2018):3583-3592. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
song2018.pdf(1305KB) | 期刊论文 | 作者接受稿 | 开放获取 | CC BY-NC-SA | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论